MedPro Safety Products and Weimer Pharma Announce Marketing Partnership

EVC GroupDoug Sherk/Jenifer Kirtland, 415-568-9349 (Investors)Chris Gale, 646-201-5431 (Media)

MedPro Safety Products, Inc. (OTCQB:MPSP), a leading developer of transformational technologies that enable safer medication delivery and blood collection, and Weimer Pharma GmbH, a Körber Medipak company, today announced that they have agreed to a preferred marketing partnership.

MedPro’s innovative Drug Delivery Platform will now be offered to Weimer Pharma’s customer base as the premium drug delivery solution. Utilizing Weimer Pharma’s cartridge filling capability, this partnership will offer the pharmaceutical industry a turnkey solution for its injectable needs. Weimer Pharma is one of a small group of companies worldwide providing cartridge filling services, serving more than 80 pharmaceutical companies.

The Weimer Pharma-filled cartridge can be used with any of the three elements of MedPro’s platform. The passive safety syringe is a fully automatic and fully passive safety sharp. The cartridge can be inserted to inject the medication without concern for needlestick injuries, due to the shield that automatically covers the syringe’s needle after use. The cartridge can also be inserted into the intravenous shuttle to administer the medication through any standard intravenous line. Finally, the cartridge can be enclosed in the cartridge vial, allowing the medication to be accessed for injection in smaller doses from the same cartridge.

The combined features of the platform provide greater safety to the patient, primarily by helping to ensure proper dosing, as well as increasing clinician and community safety by preventing needlestick injuries and the potential spread of bloodborne pathogens.

“We designed our Drug Delivery Platform to reduce the hurdles for adoption by pharmaceutical companies,” said Wm. Craig Turner, Chairman and CEO of MedPro. “Partnering with a world class company like Weimer Pharma allows us to provide another solution to pharmaceutical customers looking for an answer to their packaging needs.”

“The innovative MedPro Drug Delivery Platform fits perfectly with our Cartridge Fill + Finish Services,” said Dr. Ulrich Nütz, Managing Director at Weimer Pharma. “The complete system offers a new dimension in patient convenience and compliance combined with the advantages of the Weimer cartridge filling process.”

Headquartered in Lexington, Kentucky, MedPro Safety Products, Inc. is a leading developer of safer medication delivery and blood collection systems. The Company licenses, develops and manufactures transformational technologies marketed through its global medical device partners. MedPro’s products address multiple product categories within the medication delivery (injection and infusion) and blood collection (blood collection sets and blood tube holders) markets. Unlike competitive products currently available on the market, MedPro’s products incorporate safety features that operate without user activation, and therefore require little or no clinician training to use. The total global market opportunity for safer medication delivery and blood collection products is believed to be more than $6 billion. For additional information, please refer to the ‘Investor Relations’ link on the Company’s website ().

"Valuable Solutions" at Weimer Pharma.For 70 years Weimer Pharma has been a renowned contract manufacturer and developer for pharmaceutical companies in Europe and beyond. The company is a competent partner for customers in all aspects of pharmaceutical manufacturing, ranging from development, to regulatory affairs, manufacturing, packaging, logistics and quality control. As a leader in cartridge solutions, Weimer Pharma’s specialty is the manufacturing of parenterals. The company also offers a wide range of production options and outsourcing solutions for solid and liquid doses.()

Virtual Clinical Trials Summit

Virtual Clinical Trials Summit: The Premier Educational Event Focused on Decentralized Clinical Trials

In this virtual environment, we will look at current and future trends for ongoing virtual trials, diving into the many ways companies can improve patient engagement and trial behavior to enhance retention with a focus on emerging technology and harmonized data access across the clinical trial system.